|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-12-16
|
|
pubmed:abstractText |
To determine the role of matrix metalloproteinase 9 (MMP9) in advanced glycation end-products (AGEs) induced damage to blood-retinal barrier (BRB) and the therapeutic effects of minocycline, an MMP inhibitor, against the BRB damages.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1460-2202
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
977-83
|
|
pubmed:meshHeading |
pubmed-meshheading:19085380-Animals,
pubmed-meshheading:19085380-Capillary Permeability,
pubmed-meshheading:19085380-Drug Combinations,
pubmed-meshheading:19085380-Enzyme Inhibitors,
pubmed-meshheading:19085380-Glycosylation End Products, Advanced,
pubmed-meshheading:19085380-Male,
pubmed-meshheading:19085380-Matrix Metalloproteinase 9,
pubmed-meshheading:19085380-Microcirculation,
pubmed-meshheading:19085380-Minocycline,
pubmed-meshheading:19085380-RNA, Messenger,
pubmed-meshheading:19085380-Rats,
pubmed-meshheading:19085380-Rats, Sprague-Dawley,
pubmed-meshheading:19085380-Retina,
pubmed-meshheading:19085380-Retinal Vessels,
pubmed-meshheading:19085380-Serum Albumin, Bovine,
pubmed-meshheading:19085380-Up-Regulation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline.
|
|
pubmed:affiliation |
Department of Ophthalmology, The First People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article
|
